Atrial fibrillation as the initial clinical manifestation of cardiac sarcoidosis: A case report and review of the literature

Journal of Cardiovascular Medicine

Volumn 16, Issue , 2015, Pages S104-S112

  Golwala, Harsh ^a   Dernaika, Tarek ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

cardiac sarcoidosis; case report; imaging; thallium scan

Indexed keywords

ATRIAL FIBRILLATION; CASE REPORT; COMPLICATION; HUMAN; MALE; MIDDLE AGED; SARCOIDOSIS;

ATRIAL FIBRILLATION; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS;

EID: 84942598738     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328343b589     Document Type: Review

References (32)

1. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: A 5 year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241.
2. Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann NY Acad Sci 1976; 278:455-469.
3. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63:86-108.
4. Fleming HA. Cardiac sarcoidosis. Semin Respir Med 1986; 8:65-71.
5. Yazaki Y, Isobe M, Hiramitsu S, Morimoto S, Hiroe M, Omichi C, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998; 82:537-540.
6. Uijlings R, Balt JC, Boom P, Wever E. Cardiac sarcoidosis mimicking non- ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 2010. [Epub ahead of print]
7. Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E, Gomes JA. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991; 18:937-943.
8. Mezaki T, Chinushi M, Washizuka T, Furushima H, Chinushi Y, Ebe K, et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med 2001; 40:731-735.
9. Verkleeren JL, Glover MU, Bloor C, Joswig BC. Cardiac tamponade secondary to sarcoidosis. Am Heart J 1983; 106:601-603.
10. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88:1006-1010.
11. Shiraishi J, Tatsumi T, Shimoo K, Katsume A, Mani H, Kobara M, et al. Cardiac sarcoidosis mimicking right ventricular dysplasia. Circ J 2003; 67:169-171.
12. Fahy GJ, Marwick T, McCreery CJ, Quigley PJ, Maurer BJ. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996; 109:62-66.
13. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173.
14. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: The ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86.
15. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disorders 2007; 27:89-102.
16. Uemura A, Morimoto S, Kato Y, Hiramitsu S, Ohtsuki M, Kato S, et al. Relationship between basal thinning of the interventricular septum and atrioventricular block in patients with cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:63-65.
17. Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, Kasper EK. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 2005; 150:459-463.
18. Bulkley BH, Rouleau JB, Whitaker JQ, Strauss HW, Pitt B. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 1977; 72:27-32.
19. Tellier P, Valeyre A, Nitenberg A, Foult JM, Bedig G, Battesti JP. Cardiac sarcoidosis: Reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med 1985; 11:201-204.
20. Fields CL, Ossorio MA, Roy TM, Denny DM, Varga DW. Thallium 201 scintigraphy in the diagnosis the management of myocardial sarcoidosis. South Med J 1990; 83:339-342.
21. Brudin LH, Valind S, Rhodes CG, Pantin CF, Sweatman M, Jones T, Hughes JM. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21:297- 305.
22. Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008; 35:933-941.
23. Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K, Yoshikawa J. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)FFDG PET. J Nucl Med 2003; 44:1030-1036.
24. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45:1683- 1690.
25. Ayyala US, Nair AP, Padilla ML. Cardiac sarcoidosis. Clin Chest Med 2008; 29:493-508.
26. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. ACC/ AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2008; 51:1-62.
27. Zaidi AR, Zaidi A, Vaitkus PT. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 2007; 26:714-717.
28. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report 2007. J Heart Lung Transplant 2007; 26:769-781.
29. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, et al., Transplantation Group of The Heart Centre. Thorax transplantations - Rigshospitalet 1990-2002. The first 500 heart-, lung- and heart-lung transplantations. Ugeskr Laeger 2003; 165:4736-4740.
30. Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM, et al. Recurrence of sarcoidosis in a cardiac allograft: Control with augmented corticosteroids. J Heart Lung Transplant 1992; 11:367-369.
31. Yager JEE, Hernandez AF, Steenbergen C, Persing B, Russell SD, Milano C, et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant 2005; 24:1988-1990.
32. Strecker T, Zimmermann I, Wiest GH. Pulmonary and cardiac recurrence of sarcoidosis in a heart transplant recipient. Dtsch Med Wochenschr 2007; 132:1159-1162.